What's happening
This bill strengthens regulations and oversight of pharmacy benefit managers in New York, including stricter licensing, reporting, and penalties.
Why it matters
Tougher Penalties and Damages. The bill significantly increases financial penalties for unlicensed or unlawful actions by pharmacy benefit managers (PBMs), and adds new requirements for PBMs to pay restitution and compensatory damages directly to any health plans, pharmacies, or individuals harmed by violations. This could create stronger incentives for PBMs to comply with regulations and offer more meaningful remedies for those affected by PBM practices.
Expanded Regulatory Powers and Oversight. The bill gives the Superintendent of Financial Services broader authority to oversee PBMs, including the power to define regulations, limit administrative fees, and require detailed reporting. It also allows for more frequent examinations and the ability to set standards that address conflicts of interest, anti-competitive practices, and consumer protection—potentially leading to greater transparency and less market abuse.
Broader Accountability and Scope. PBMs are now explicitly responsible for the actions of their subcontractors, affiliates, and subsidiaries, even if they were unaware of violations. The bill also clarifies and expands who is covered under the law, including health plans with a “substantial number” of New Yorkers, and strengthens requirements for PBMs to support health plans in regulatory inquiries.
Direct Impact on Pharmacies, Consumers, and the State. The bill prohibits gag clauses that stop pharmacists from discussing drug costs or alternatives and protects consumers from being charged more in copays than the actual pharmacy cost. It also establishes a dedicated regulatory fund for PBM oversight, with all PBM fees and penalties going directly to support enforcement, which may result in more robust and sustained regulatory activity.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
Regulate Prescription Drug Middlemen
Plain English, a few words. Used as the page title.
Sponsors
No co-sponsors yet.
History
- Signed chap.128
- Delivered to governor
- Returned to senate
- Passed assembly
- Ordered to third reading cal.403
- Substituted for A8838
- Referred to health
- Delivered to assembly
- Passed senateVote 62–1
- Ordered to third reading cal.195
- Referred to rules
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Regulate Pharmacy Benefit Managers
Assembly Floor Calendar · Sponsor Richard Gottfried
Full text
13 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
7837
IN SENATE
January 12, 2022
Introduced by Sen. BRESLIN -- read twice and ordered printed, and when printed to be committed to the Committee on Rules
AN ACT to amend the public health law, in relation to pharmacy benefit managers; to amend the insurance law, in relation to registration and licensing of pharmacy benefit managers; to amend the state finance law, in relation to establishing the pharmacy… Show allHide
AN ACT to amend the public health law, in relation to pharmacy benefit managers; to amend the insurance law, in relation to registration and licensing of pharmacy benefit managers; to amend the state finance law, in relation to establishing the pharmacy benefit manager regulatory fund; and to amend a chapter of the laws of 2021 amending the public health law relating to pharmacy benefit managers; amending the insurance law relating to registration and licensing of pharmacy benefit managers; and repealing certain provisions of the public health law relating thereto, as proposed in legislative bills numbers S.3762 and A.1396, in relation to the effectiveness thereof
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Subdivisions 1, 2, 3 and 5 of section 280-a of the public health law, as added by a chapter of the laws of 2021 amending the public health law relating to pharmacy benefit managers; amending the insurance law relating to registration and licensing of pharmacy benefit managers; and repealing certain provisions of the public health law relating thereto, as proposed in legislative bills numbers S. 3762 and A. 1396, are amended to read as follows:
1. Definitions. As used in this section, the following terms shall have the following meanings:
(a) "Health plan [or provider]" means an entity for which a pharmacy benefit manager provides pharmacy benefit management [including, but not limited to: (i)] services and that is a health benefit plan or other entity that approves, provides, arranges for, or pays or reimburses in whole or in part for health care items or services, [under which] to include at least prescription drugs, for a substantial number of beneficiaries [of the entity are purchased or which provides or arranges reimbursement in whole or in part for the purchase of prescription drugs; or (ii) a health care provider or professional that acquires prescription drugs to use or dispense in providing health care to patients where the prescription drug is the subject of the pharmacy
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD00570-04-2
benefit manager's pharmacy benefit management services] who work or reside in this state. The superintendent shall determine, in his or her sole discretion, by regulation how the phrase "a substantial number of beneficiaries who work or reside in this state" shall be interpreted.
(b) "Pharmacy benefit management services" means the [service provided to] management or administration of prescription drug benefits for a health plan [or provider], directly or through another entity, and regardless of whether the pharmacy benefit manager and the health plan [or provider] are related, or associated by ownership, common ownership, organization or otherwise; including the procurement of prescription drugs to be dispensed to patients, or the administration or management of prescription drug benefits, including but not limited to, any of the following:
(i) mail service pharmacy;
(ii) claims processing, retail network management, or payment of claims to pharmacies for dispensing prescription drugs;
(iii) clinical or other formulary or preferred drug list development or management;
(iv) negotiation or administration of rebates, discounts, payment differentials, or other incentives, for the inclusion of particular prescription drugs in a particular category or to promote the purchase of particular prescription drugs;
(v) patient compliance, therapeutic intervention, or generic substitution programs;
(vi) disease management;
(vii) drug utilization review or prior authorization;
(viii) adjudication of appeals or grievances related to prescription drug coverage;
(ix) contracting with network pharmacies; and
(x) controlling the cost of covered prescription drugs.
(c) "Pharmacy benefit manager" means any entity that performs pharmacy benefit management services for a health plan [or provider].
(d) "Maximum allowable cost price" means a maximum reimbursement amount set by the pharmacy benefit manager for therapeutically equivalent multiple source generic drugs.
(e) "Controlling person" means any person or other entity who or which directly or indirectly has the power to direct or cause to be directed the management, control or activities of a pharmacy benefit manager.
(f) "Covered individual" means a member, participant, enrollee, contract holder or policy holder or beneficiary of a health plan [or provider].
(g) "License" means a license to be a pharmacy benefit manager, under article twenty-nine of the insurance law.
(h) "Spread pricing" means the practice of a pharmacy benefit manager retaining an additional amount of money in addition to the amount paid to the pharmacy to fill a prescription.
(i) "Superintendent" means the superintendent of financial services.
2. Duty, accountability and transparency. (a) (i) The pharmacy benefit manager shall have a duty and obligation to [the covered individual and the health plan or provider, and shall] perform pharmacy benefit management services with care, skill, prudence, diligence, and professionalism[, and for the best interests of the covered individual, and the health plan or provider. Where there is a conflict in the pharmacy benefit manager's duty or obligation under this paragraph to the covered individual and any other party, the duty or obligation to the covered individual shall be primary].
(ii) In addition to the duties as may be prescribed by regulation pursuant to article twenty-nine of the insurance law:
(1) A pharmacy benefit manager interacting with a covered individual shall have the same duty to a covered individual as the health plan for whom it is performing pharmacy benefit management services.
(2) A pharmacy benefit manager shall have a duty of good faith and fair dealing with all parties, including but not limited to covered individuals and pharmacies, with whom it interacts in the performance of pharmacy benefit management services.
(b) All funds received by the pharmacy benefit manager in relation to providing pharmacy benefit management services shall be received by the pharmacy benefit manager in trust [for the health plan or provider] and shall be used or distributed only pursuant to the pharmacy benefit manager's contract with the health plan [or provider] or applicable law; including any administrative fee or payment to the pharmacy benefit manager expressly provided for in the contract to compensate the pharmacy benefit manager for its services. Any funds received by the pharmacy benefit manager through spread pricing shall be subject to this paragraph. In addition to any other power conferred by law the superintendent shall have the authority to prescribe rules concerning pharmacy benefit manager administrative fees, including limitations on their form and use.
(c) The pharmacy benefit manager shall account, annually or more frequently to the health plan [or provider] for any pricing discounts, rebates of any kind, inflationary payments, credits, clawbacks, fees, grants, chargebacks, reimbursements, or other benefits received by the pharmacy benefit manager. [The pharmacy benefit manager shall ensure that any portion of such income, payments, and financial benefits is passed through to the health plan or provider in full to reduce the reportable ingredient cost.] The health plan [or provider] shall have access to all financial and utilization information of the pharmacy benefit manager in relation to pharmacy benefit management services provided to the health plan [or provider].
(d) The pharmacy benefit manager shall disclose in writing to the health plan [or provider] the terms and conditions of any contract or arrangement between the pharmacy benefit manager and any party relating to pharmacy benefit management services provided to the health plan [or provider] including but not limited to, dispensing fees paid to the pharmacies.
(e) The pharmacy benefit manager shall disclose in writing to the health plan [or provider] any activity, policy, practice, contract or arrangement of the pharmacy benefit manager that directly or indirectly presents any conflict of interest with the pharmacy benefit manager's relationship with or obligation to the health plan [or provider].
(f) Any information required to be disclosed by a pharmacy benefit manager to a health plan [or provider] under this section that is reasonably designated by the pharmacy benefit manager as proprietary or trade secret information shall be kept confidential by the health plan [or provider], except as required or permitted by law, including disclosure necessary to prosecute or defend any legitimate legal claim or cause of action. Designation of information as proprietary or trade secret information under this subdivision shall have no effect on the obligations of any pharmacy benefit manager or health plan to provide that information to the department of health or the department of financial services.
(g) The superintendent, in consultation with the commissioner[:
(i)] may make regulations defining, limiting, and relating to the duties, obligations, requirements and other provisions relating to pharmacy benefit managers under this subdivision[; and
(ii) shall establish, by regulation, minimum standards for pharmacy benefit management services which shall address the elimination of: conflicts of interest between pharmacy benefit managers and covered individuals, health benefit plans and health care providers; spread pricing; and deceptive practices, anti-competitive practices, and unfair claims practices.
(h) A health care provider and a covered individual shall be deemed to be third-party beneficiaries of the duties, obligations and requirements applicable to the pharmacy benefit manager under this section and shall be entitled to legal or equitable relief for any injury or loss to the health care provider or the covered individual caused by any violation of such duties, obligations or requirements].
3. Prescriptions. A pharmacy benefit manager may not substitute or cause the substituting of one prescription drug for another in dispensing a prescription, or alter or cause the altering of the terms of a prescription, except with the approval of the prescriber or as explicitly required or permitted by law, including regulations of the department of financial services or the department of health. The superintendent and commissioner, in coordination with each other, are authorized to promulgate regulations to determine when substitution of prescription drugs may be required or permitted.
5. Contract provisions. No pharmacy benefit manager shall, with respect to contracts between such pharmacy benefit manager and a pharmacy or, alternatively, such pharmacy benefit manager and a pharmacy's contracting agent, such as a pharmacy services administrative organization:
(a) prohibit or penalize a pharmacist or pharmacy from disclosing to an individual purchasing a prescription medication information regarding:
(i) the cost of the prescription medication to the individual, or
(ii) the availability of any therapeutically equivalent alternative medications or alternative methods of purchasing the prescription medication, including but not limited to, paying a cash price; or
(b) charge or collect from an individual a copayment that exceeds the total submitted charges by the pharmacy for which the pharmacy is paid. If an individual pays a copayment, the pharmacy shall retain the adjudicated costs and the pharmacy benefit manager shall not redact or recoup the adjudicated cost[; or
(c) require a pharmacy to meet any pharmacy accreditation standard or recertification requirement inconsistent with, more stringent than, or in addition to federal and state requirements for licensure as a pharmacy].
§ 2. Article 29 of the insurance law, as added by a chapter of the laws of 2021 amending the public health law relating to pharmacy benefit managers; amending the insurance law relating to registration and licensing of pharmacy benefit managers; and repealing certain provisions of the public health law relating thereto, as proposed in legislative bills numbers S. 3762 and A. 1396, is amended to read as follows:
ARTICLE 29
PHARMACY BENEFIT MANAGERS Section 2901. Definitions.
2902. Acting without a registration.
2903. Registration requirements for pharmacy benefit managers.
2904. Reporting requirements for pharmacy benefit managers.
2905. Acting without a license.
2906. Licensing of a pharmacy benefit manager.
2907. Revocation or suspension of a registration or license of a
pharmacy benefit manager.
2908. Penalties for violations.
2909. Stay or suspension of superintendent's determination.
2910. Revoked registrations or licenses.
2911. Additional obligations.
2912. Change of address.
[2912.] 2913. Applicability of other laws.
[2913.] 2914. Assessments.
§ 2901. Definitions. For purposes of this article:
(a) "Controlling person" is any person or other entity who or which directly or indirectly has the power to direct or cause to be directed the management, control or activities of a pharmacy benefit manager.
(b) The terms "covered individual", "health plan [or provider]", "pharmacy benefit manager" and "pharmacy benefit management services" have the same meanings as defined by section two hundred eighty-a of the public health law. The superintendent is expressly authorized to interpret these terms as if the definitions were stated within this article.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to amend the public health law, in relation to pharmacy benefit managers; to amend the insurance law, in relation to registration and licensing of pharmacy benefit managers; to amend the state finance law, in relation to establishing the pharmacy benefit manager regulatory fund; and to amend a chapter of the laws of 2021 amending the public health law relating to pharmacy benefit managers; amending the insurance law relating to registration and licensing of pharmacy benefit managers; and repealing certain provisions of the public health law relating ther- eto, as proposed in legislative bills numbers S.3762 and A.1396, in relation to the effectiveness thereof
Purpose
This is a chapter amendment that makes changes to provisions of L. 2021, c.828, to regulate pharmacy benefit managers.
Summary of provisions
This legislation amends the underlying chapter by:
Read the full memo (741 words)
-Forwarding the timeline of the bill's actions to 2022-2024. -Eliminating references to "providers" unless warranted. Since pharmacy benefit managers (PBMs) are contractual agents for the insurer when dealing with pharmacies, including providers in the definition of a health plan would confuse the relationship between PBMs, insurers, and pharmacies. -Including Employee Retirement Income Security Act (ERISA) self-funded plans in the definition of a health plan. -Identifying the bill's jurisdiction over entities. This legislation adds "substantial number" language (PBMs need to provide services for a "substantial number of beneficiaries" to fall under Department of Finan- cial Services (DFS) regulation) to create a jurisdictional limitation. -Clarifying language in relation to duty, accountability, and transpar- ency language. It clarifies that PBMs owe a duty to covered individuals and pharmacies with whom they interact. -Eliminating language to ensure discounts are passed through. These are already addressed in different parts of the bill. -Eliminating minimum standards language in the Public Health Law portion of the underlying chapter since it is already included in the Insurance Law portion of it. -Eliminating the private right of action. As an alternative, there is a verified complaint procedure that anyone could use, and it would trigger a revocation hearing. Additionally, it adds restitution and compensatory damages. -Eliminating language in the Public Health Law portion prohibiting PBMs from requiring pharmacies to meet additional accreditation standards. This will be addressed via minimum standards in the Insurance Law portion of the underlying chapter. -Authorizing DFS to interpret meanings in the Public Health Law sections of the bill. -Adding restitution and compensatory damages in registration and licens- ing sections, and adds "other person" to restitution damages language. This will ensure anyone can receive restitution and compensatory damages (even consumers) from the verified complaint process. -Increasing fees for registration, licensing, and penalties. -Eliminating language allowing disclosure via court of PBM materials under DFS control. -Adding DFS regulatory authorities under licensing language. -Eliminating "officers" and "sublicensee" language since DFS would license companies, not individuals. -Changing the license renewal timeframe to two months before expiration since not all licenses will expire on December 31. -Eliminating language to issue a notice and hearing when refusing to renew a license since there is no due process requirement for a hearing on a license nonrenewal. -Eliminating "in lieu" language for penalties to ensure additional redressable choices. -Adding language obligating PBMs to cooperate with plans when answering DFS inquiries. -Clarifying that PBMs cannot violate Public Health Law provisions. Adding language to hold subcontract and PBM affiliates accountable as if they were regulated PBMs. -Clarifying that PBM assessments are different from 206 assessments. -Changing the severability clause to account for provisions and applica- tions of the law. -Adding a PBM Regulatory Fund to collect the fees from licensing, penal- ties, etc., that would allow DFS to have the money necessary to run the PBM program. -Changing the underlying chapter's effective date to immediately.
Existing law
None.
Justification
This legislation is a negotiated change to the underlying chapter to allow a payer to impose standards on pharmacies to address what would have been a significant fiscal impact to the State. It clarifies defi- nitions to avoid confusion and ensure the regulated community understand the duties imposed by the underlying chapter, and clarifies that DFS is the entity that will pursue violations of the law, ensuring that PBMs adhere to the law and the underlying chapter.
Legislative history
Chapter amendment to Chapter 828 of the Laws of 2021. S.3762 and A.1396 both passed the Senate and Assembly, respectfully, in June 2021.
Fiscal implications
None.
Effective date
This act shall take effect immediately.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.